Cytokine Responses to Novel Antigens in an Indian Population Living in an Area Endemic for Visceral Leishmaniasis

Reassessment of Immune Correlates in Human Visceral Leishmaniasis as Defined by Cytokine Release in Whole Blood

(2012) Om Prakash Singh et al.   Clinical and Vaccine Immunology

Leishmaniasis Worldwide and Global Estimates of Its Incidence

(2012) Jorge Alvar et al.   PLoS One

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis

(2011) Jaya Chakravarty et al.   VACCINE

The development and clinical evaluation of second-generation leishmaniasis vaccines

(2011) Malcolm S. Duthie et al.   VACCINE

Incidence of Symptomatic and Asymptomatic Leishmania donovani Infections in High-Endemic Foci in India and Nepal: A Prospective Study

(2011) Bart Ostyn et al.   PLoS Neglected Tropical Diseases

Interferon-Gamma Release Assay (Modified QuantiFERON) as a Potential Marker of Infection for Leishmania donovani, a Proof of Concept Study

(2011) Kamlesh Gidwani et al.   PLoS Neglected Tropical Diseases

TLR1/2 Activation during Heterologous Prime-Boost Vaccination (DNA-MVA) Enhances CD8+ T Cell Responses Providing Protection against Leishmania (Viannia)

(2011) Asha Jayakumar et al.   PLoS Neglected Tropical Diseases

Immunization with the DNA-Encoding N-Terminal Domain of Proteophosphoglycan of Leishmania donovani Generates Th1-Type Immunoprotective Response against Experimental Visceral Leishmaniasis

(2009) M. Samant et al.   JOURNAL OF IMMUNOLOGY

Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis—A meta-analysis

(2009) Sassan Noazin et al.   VACCINE

Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection againstLeishmania

(2008) Blaise Dondji et al.   EUROPEAN JOURNAL OF IMMUNOLOGY